
Biocure Technology Inc. — Investor Relations & Filings
Biocure Technology Inc. is a biopharmaceutical company specializing in the development and commercialization of advanced biological medicines. The company's core focus areas include proprietary CAR T-cell therapies designed to treat various cancers, such as leukemia, lung, and breast cancer. Concurrently, Biocure is engaged in the development and commercialization of major biosimilar pharmaceutical products, aiming to improve the accessibility of complex biological treatments. Furthermore, the company pursues novel, highly-efficacious therapies for severe diseases caused by RNA viruses where significant unmet medical needs exist.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-13 | English | |
| ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF | 2026-04-15 | English | |
| 52-109FV1 - Certification of annual filings - CEO (E).pdf | 2026-04-15 | English |
Browse filings by year
19 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Cyclerion Therapeutics, Inc.
Develops personalized biofeedback therapies for treatment-r…
|
CYCN | US | Manufacturing |
|
Cyfuse Biomedical K.K.
Develops scaffold-free bio 3D printing technology for tissu…
|
4892 | JP | Manufacturing |
|
CYTOKINETICS INC
A late-stage biopharma developing drugs for diseases of imp…
|
CYTK | US | Manufacturing |
|
CytomX Therapeutics, Inc.
Clinical-stage oncology company developing conditionally ac…
|
CTMX | US | Manufacturing |
|
Cytori Cell Research Institute,Inc.
Develops cell therapy medical devices using a patient's own…
|
3750 | JP | Manufacturing |
|
Daan Gene Co., Ltd.
Specializes in molecular diagnostic products and PCR-based …
|
002030 | CN | Manufacturing |
|
Daebonglsco.,Ltd
Develops and supplies raw materials for the pharmaceutical,…
|
078140 | KR | Manufacturing |
|
DaehanPharmaceutical
Researches, develops, and manufactures human/animal pharma …
|
023910 | KR | Manufacturing |
|
DAE HWA PHARM CO., LTD
Pharmaceutical firm developing drugs with proprietary drug …
|
067080 | KR | Manufacturing |
|
Daesung Microbiological Labs. Co. Ltd
Develops, manufactures, and distributes animal pharmaceutic…
|
036480 | KR | Manufacturing |
Biocure Technology Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46211/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46211 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46211 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46211 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46211}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biocure Technology Inc. (id: 46211)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.